
NeurologyLive® Friday 5 — August 21, 2026
Key Takeaways
- Concussion management increasingly emphasizes individualized assessment, evolving diagnostic approaches, and tailored rehabilitation amid persistent clinical challenges.
- FDA agreement on ATH434’s Phase 3 program defines a clearer development route for a potential disease-modifying therapy in multiple system atrophy.
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending August 21, 2026.
Welcome to NeurologyLive®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.
Click the read more or watch now buttons for more details and information about each highlight.
1: Exploring the Evolving Approach to Concussion Care
In a recent Q&A interview, Kyle Marden, MD, sports neurologist and medical director of the Concussion and Sports Neurology Program at
2: ATH434's Phase 3 Path Is Set: Alterity on What FDA Alignment Means for MSA
In a recent Q&A interview, David Stamler, MD, Chief Executive Officer of Alterity Therapeutics, discusses the FDA's alignment on the pivotal Phase 3 program for ATH434 in multiple system atrophy and what a successful trial could mean for a disease with no approved disease-modifying therapies.
3: Evolving Dieting Strategies Address New Challenges in SMA Care
In a recent Q&A interview, Stacey Tarrant, RD, LDN, a dietitian at Boston Children’s Hospital, discusses how earlier treatment alongside disease-modifying therapies have changed nutritional priorities in spinal muscular atrophy, including the need to optimize growth, strength, function, and body composition.
4: NeuroVoices: Young Lee, MD, on Applying Newly FDA Cleared THUNDERBOLT Stroke Thrombectomy
In our latest NeuroVoices Q&A, Young Lee, MD, cerebrovascular neurosurgeon at University Medical Center New Orleans, discussed performing the first THUNDERBOLT stroke thrombectomy in the United States and what computer-assisted vacuum thrombectomy offers over traditional aspiration.
5: Why Effective Care in SMA Requires More Than a Neurologist: W. Bryan Burnette, MD
In a recent video interview,
Which conversation stood out most to you in this week’s NeurologyLive Friday Five?
Don’t have time to read or watch a full video interview?
















